US FDA gives record number of review designations to CRISPR drugs in 2023: GlobalData
Casgevy is the first CRISPR-based drug to receive marketing authorisation globally
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
sickle cell disease
US FDA approves Casgevy, cell-based gene therapy to treat transfusion-dependent beta-thalassemia
The approval signifies a second FDA-approved indication for Casgevy, as the product was also recently approved for the treatment…